Showing results (1451-1460 of 5,384) with videos related to
Sort By:
Pageof 539
European Heart Journal|March 13, 2018
Deferred vs. performed revascularization for coronary stenosis with grey-zone fractional flow reserve values: data from the IRIS-FFR registryDo-Yoon Kang, Jung-Min Ahn, Cheol Hyun Lee, et al.Circulation. Cardiovascular Interventions|March 28, 2013
Association of body mass index with major cardiovascular events and with mortality after percutaneous coronary interventionDuk-Woo Park, Young-Hak Kim, Sung-Cheol Yun, et al.Korean Circulation Journal|June 2, 2017
Coronary Artery Bypass Grafting vs. Drug-Eluting Stent Implantation for Multivessel Disease in Patients with Chronic Kidney DiseaseSe Hun Kang, Cheol Whan Lee, Sung-Cheol Yun, et al.Circulation. Cardiovascular Interventions|July 14, 2017
Differential Event Rates and Independent Predictors of Long-Term Major Cardiovascular Events and Death in 5795 Patients With Unprotected Left Main Coronary Artery Disease Treated With Stents, Bypass Surgery, or Medication: Insights From a Large International Multicenter RegistrySe Hun Kang, Jung-Min Ahn, Cheol Hyun Lee, et al.The American Journal of Cardiology|February 12, 2014
Impact of the angiographic mechanisms underlying periprocedural myocardial infarction after drug-eluting stent implantationDuk-Woo Park, Young-Hak Kim, Sung-Cheol Yun, et al.Circulation. Cardiovascular Interventions|January 10, 2018
Comparison of a Simple Angiographic Approach With a Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery Score-Based Approach for Left Main Coronary Artery Stenting: A Pooled Analysis of Serial PRECOMBAT (Premier of Randomized Comparison of Bypass Surgery Versus Angioplasty Using Sirolimus-Eluting Stent in Patients With Left Main Coronary Artery Disease) StudiesPil Hyung Lee, Jong-Young Lee, Cheol Whan Lee, et al.International Journal of Cardiology|January 16, 2009
Serum B-type natriuretic peptide on admission can predict the 'no-reflow' phenomenon after primary drug-eluting stent implantation for ST-segment elevation myocardial infarctionYoung-Hoon Jeong, Won-Jang Kim, Duk-Woo Park, et al.American Heart Journal|February 16, 2010
Triple antiplatelet therapy reduces ischemic events after drug-eluting stent implantation: Drug-Eluting stenting followed by Cilostazol treatment REduces Adverse Serious cardiac Events (DECREASE registry)Seung-Whan Lee, Seong-Wook Park, Sung-Cheol Yun, et al.JACC. Cardiovascular Interventions|May 22, 2017
Prevalence, Management, and Long-Term (6-Year) Outcomes of Atrial Fibrillation Among Patients Receiving Drug-Eluting Coronary StentsHyo-In Choi, Jung-Min Ahn, Se Hun Kang, et al.Circulation|November 4, 2009
C-reactive protein and the risk of stent thrombosis and cardiovascular events after drug-eluting stent implantationDuk-Woo Park, Sung-Cheol Yun, Jong-Young Lee, et al.Pageof 539